ARTICLE | Company News
Proteologics, Teva Pharmaceuticals Industries Ltd. deal
May 9, 2005 7:00 AM UTC
Proteologics will run a feasibility study to discover cancer compounds that target ubiquitin ligases. TEVA will have an option to license resulting discoveries in exchange for milestones and royalties...